SNTI · Senti Biosciences, Inc.

Summary

Senti Biosciences, Inc. entered into a First Amendment to Lease effective September 1, 2025, reducing leased premises from approximately 91,910 to 45,955 rentable square feet and monthly base rent starting at $188,311, with the landlord entitled to draw $2.0 million from the company's letter of credit. Related amendments to sublease with GeneFab, LLC and landlord consent involve matching rent terms, a $1.0 million reduction fee, and settlement of GeneFab's $1,374,005 outstanding rent via prepayment credit.

Key takeaways

• Leased premises reduced from ~91,910 to ~45,955 rentable sq ft effective 2025-09-01
• Monthly base rent: $188,311 (2025-09-01 to 2026-07-31), $193,960 (2026-08-01 to 2027-07-31), up to $293,010 (2022-08-01 to 2032-08-31)
• Landlord draws $2.0M from $2.76M letter of credit; remaining LC reduced to $760,000
• Sublease with GeneFab amended to match reduced premises and rent terms
• GeneFab or Company pays $1.0M Reduction Fee to landlord
• GeneFab's $1,374,005 outstanding rent satisfiable via prepayment credit by 2026-09-01; potential $2.0M additional credit